HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 31,600
-2,300 (-6.78%)
At close: Oct 8, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 227.81 billion as of October 8, 2026. It is the 21,912th most valuable company in the world and the 807th biggest in South Korea. Its market cap has increased by 15.72% in one year.
Market Cap
227.81B
Enterprise Value
239.50B
Revenue
16.14B
Global Rank
Country Rank
#807 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 227.81B, an increase of 99.52%. That is a compound annual growth rate of 43.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 227.81B | -30.44% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 301.63B |
| DAE HWA Pharmaceutical | 221.07B |
| GC WellBeing | 194.64B |
| Vivozon Pharmaceutical | 181.10B |
| NOVAREX | 180.45B |
| CellBion | 175.25B |
| Kyung Dong Pharmaceutical | 148.84B |
| HYUNDAI BIOLAND | 145.50B |